Collegium Pharmaceutical
COLL
COLL
128 hedge funds and large institutions have $405M invested in Collegium Pharmaceutical in 2019 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 53 increasing their positions, 32 reducing their positions, and 37 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
12% less funds holding
Funds holding: 145 → 128 (-17)
15% less capital invested
Capital invested by funds: $476M → $405M (-$70.8M)
38% less first-time investments, than exits
New positions opened: 23 | Existing positions closed: 37
Holders
128
Holding in Top 10
1
Calls
$1.16M
Puts
$735K
Top Buyers
| 1 | +$9.12M | |
| 2 | +$3.21M | |
| 3 | +$3.16M | |
| 4 |
CAM
Cortina Asset Management
Milwaukee,
Wisconsin
|
+$3M |
| 5 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
+$2.9M |
Top Sellers
| 1 | -$25.2M | |
| 2 | -$5.98M | |
| 3 | -$3.57M | |
| 4 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$3.03M |
| 5 |
JGC
J. Goldman & Co
New York
|
-$2.63M |